Project name: DISARM: Disarming the silent threat of ovarian cancer

Project start date: 1. 9. 2025
Project completion date: 31. 8. 2029
Project Budget: total 13,202,499.25 EUR (of which 118,468.75 EUR for VFN)
Project guarantor: Oncology Clinic, Assoc. Prof. Michal Vočka, Ph.D.
Project Registration Number: 101214318

This project is funded by the European Union under the National Recovery Plan. 

Project brief:

The project is supported by the EU Horizon EUROPE program and will be implemented by an international consortium including 28 entities from 12 countries.

The project coordinator is the Institute of Communication & Computer Systems (ICCS), Greece, VFN is one of the partners.

The main objective of the DISARM project is to improve the identification of individuals at increased risk of ovarian cancer and to implement procedures that have shown promise for early detection of the disease.

The DISARM project includes the following key pillars:

Pillar A focuses on the assessment of hereditary breast cancer risk in routine healthcare and examines multifactorial risk stratification compared to standard practices in 4 EU Member States (Lithuania, Portugal, Czech Republic, Greece).

Pillar B focuses on early detection of breast cancer and includes a set of easy-to-use, highly accurate and affordable technologies to be scaled up and validated in 5 countries (United Kingdom, Lithuania, Portugal, Czech Republic, Greece).

Pillar C includes several digital and AI technologies that can optimally support and improve risk assessment (Pillar A) and early detection (Pillar B) in routine healthcare.

Pillar D includes activities to ensure, implement and adopt DISARM solutions in routine healthcare.